Market News AIOpen the app

BioCardia, Inc.: Other Events (BCDA)

RulesRead the original at SEC EDGAR
Good for BCDA

BioCardia has moved a step forward toward clearance for its Helix catheter. FDA review and a meeting remain ahead, so this is progress, not clearance.

BCDA · BioCardia, Inc.

AI read · Good for BCDA

The AI's read

This gives BioCardia a step forward in its effort to bring the catheter to market. The FDA review and meeting are still ahead. The filing does not announce clearance, so this is progress rather than a completed approval.

Get alerts for BCDA

Follow BioCardia, Inc. (BCDA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BCDA
Free on the App Store and Google Play, or on the web.